Baxter International, Inc. (BAX)
19.13
+0.23
(+1.22%)
USD |
NYSE |
Dec 12, 12:07
Baxter International Research and Development Expense (Quarterly): 115.00M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Boston Scientific Corp. | 514.00M |
| Solventum Corp. | 183.00M |
| Abbott Laboratories | 748.00M |
| Insulet Corp. | 77.20M |
| ResMed, Inc. | 87.32M |